Cargando…

Comparative Effectiveness of MRI, 4D-CT and Ultrasonography in Patients with Secondary Hyperparathyroidism

OBJECTIVE: Accurate preoperative localization of abnormal parathyroid glands is crucial for successful surgical management of secondary hyperparathyroidism (SHPT). This study was conducted to compare the effectiveness of preoperative MRI, 4D-CT, and ultrasonography (US) in localizing parathyroid les...

Descripción completa

Detalles Bibliográficos
Autores principales: Mi, Jiaoping, Fang, Yijie, Xian, Jianzhong, Wang, Guojie, Guo, Yuanqing, Hong, Haiyu, Chi, Mengshi, Li, Yong-Fang, He, Peng, Gao, Jiebing, Liao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163888/
https://www.ncbi.nlm.nih.gov/pubmed/37159605
http://dx.doi.org/10.2147/TCRM.S379814
_version_ 1785037976361762816
author Mi, Jiaoping
Fang, Yijie
Xian, Jianzhong
Wang, Guojie
Guo, Yuanqing
Hong, Haiyu
Chi, Mengshi
Li, Yong-Fang
He, Peng
Gao, Jiebing
Liao, Wei
author_facet Mi, Jiaoping
Fang, Yijie
Xian, Jianzhong
Wang, Guojie
Guo, Yuanqing
Hong, Haiyu
Chi, Mengshi
Li, Yong-Fang
He, Peng
Gao, Jiebing
Liao, Wei
author_sort Mi, Jiaoping
collection PubMed
description OBJECTIVE: Accurate preoperative localization of abnormal parathyroid glands is crucial for successful surgical management of secondary hyperparathyroidism (SHPT). This study was conducted to compare the effectiveness of preoperative MRI, 4D-CT, and ultrasonography (US) in localizing parathyroid lesions in patients with SHPT. METHODS: We performed a retrospective review of prospectively collected data from a tertiary-care hospital and identified 52 patients who received preoperative MRI and/or 4D-CT and/or US and/or (99m)Tc-MIBI and subsequently underwent surgery for SHPT between May 2013 and March 2020. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of each imaging modality to accurately detect enlarged parathyroid glands were determined using histopathology as the criterion standard with confirmation using the postoperative biochemical response. RESULTS: A total of 198 lesions were identified intraoperatively among the 52 patients included in this investigation. MRI outperformed 4D-CT and US in terms of sensitivity (P < 0.01), specificity (P = 0.455), PPV (P = 0.753), and NPV (P = 0.185). The sensitivity and specificity for MRI, 4D-CT, and US were 90.91%, 88.95%, and 66.23% and 58.33%, 63.64%, and 50.00%, respectively. The PPV of combined MRI and 4D-CT (96.52%) was the highest among the combined 2 modalities. The smallest diameter of the parathyroid gland precisely localized by MRI was 8×3 mm, 5×5 mm by 4D-CT, and 5×3 mm by US. CONCLUSION: MRI has superior diagnostic performance compared with other modalities as a first-line imaging study for patients undergoing renal hyperparathyroidism, especially for ectopic or small parathyroid lesions. We suggest performing US first for diagnosis and then MRI to make a precise localization, and MRI proved to be very helpful in achieving a high success rate in the surgical treatment of renal hyperparathyroidism in our own experience.
format Online
Article
Text
id pubmed-10163888
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-101638882023-05-07 Comparative Effectiveness of MRI, 4D-CT and Ultrasonography in Patients with Secondary Hyperparathyroidism Mi, Jiaoping Fang, Yijie Xian, Jianzhong Wang, Guojie Guo, Yuanqing Hong, Haiyu Chi, Mengshi Li, Yong-Fang He, Peng Gao, Jiebing Liao, Wei Ther Clin Risk Manag Original Research OBJECTIVE: Accurate preoperative localization of abnormal parathyroid glands is crucial for successful surgical management of secondary hyperparathyroidism (SHPT). This study was conducted to compare the effectiveness of preoperative MRI, 4D-CT, and ultrasonography (US) in localizing parathyroid lesions in patients with SHPT. METHODS: We performed a retrospective review of prospectively collected data from a tertiary-care hospital and identified 52 patients who received preoperative MRI and/or 4D-CT and/or US and/or (99m)Tc-MIBI and subsequently underwent surgery for SHPT between May 2013 and March 2020. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of each imaging modality to accurately detect enlarged parathyroid glands were determined using histopathology as the criterion standard with confirmation using the postoperative biochemical response. RESULTS: A total of 198 lesions were identified intraoperatively among the 52 patients included in this investigation. MRI outperformed 4D-CT and US in terms of sensitivity (P < 0.01), specificity (P = 0.455), PPV (P = 0.753), and NPV (P = 0.185). The sensitivity and specificity for MRI, 4D-CT, and US were 90.91%, 88.95%, and 66.23% and 58.33%, 63.64%, and 50.00%, respectively. The PPV of combined MRI and 4D-CT (96.52%) was the highest among the combined 2 modalities. The smallest diameter of the parathyroid gland precisely localized by MRI was 8×3 mm, 5×5 mm by 4D-CT, and 5×3 mm by US. CONCLUSION: MRI has superior diagnostic performance compared with other modalities as a first-line imaging study for patients undergoing renal hyperparathyroidism, especially for ectopic or small parathyroid lesions. We suggest performing US first for diagnosis and then MRI to make a precise localization, and MRI proved to be very helpful in achieving a high success rate in the surgical treatment of renal hyperparathyroidism in our own experience. Dove 2023-05-02 /pmc/articles/PMC10163888/ /pubmed/37159605 http://dx.doi.org/10.2147/TCRM.S379814 Text en © 2023 Mi et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Mi, Jiaoping
Fang, Yijie
Xian, Jianzhong
Wang, Guojie
Guo, Yuanqing
Hong, Haiyu
Chi, Mengshi
Li, Yong-Fang
He, Peng
Gao, Jiebing
Liao, Wei
Comparative Effectiveness of MRI, 4D-CT and Ultrasonography in Patients with Secondary Hyperparathyroidism
title Comparative Effectiveness of MRI, 4D-CT and Ultrasonography in Patients with Secondary Hyperparathyroidism
title_full Comparative Effectiveness of MRI, 4D-CT and Ultrasonography in Patients with Secondary Hyperparathyroidism
title_fullStr Comparative Effectiveness of MRI, 4D-CT and Ultrasonography in Patients with Secondary Hyperparathyroidism
title_full_unstemmed Comparative Effectiveness of MRI, 4D-CT and Ultrasonography in Patients with Secondary Hyperparathyroidism
title_short Comparative Effectiveness of MRI, 4D-CT and Ultrasonography in Patients with Secondary Hyperparathyroidism
title_sort comparative effectiveness of mri, 4d-ct and ultrasonography in patients with secondary hyperparathyroidism
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163888/
https://www.ncbi.nlm.nih.gov/pubmed/37159605
http://dx.doi.org/10.2147/TCRM.S379814
work_keys_str_mv AT mijiaoping comparativeeffectivenessofmri4dctandultrasonographyinpatientswithsecondaryhyperparathyroidism
AT fangyijie comparativeeffectivenessofmri4dctandultrasonographyinpatientswithsecondaryhyperparathyroidism
AT xianjianzhong comparativeeffectivenessofmri4dctandultrasonographyinpatientswithsecondaryhyperparathyroidism
AT wangguojie comparativeeffectivenessofmri4dctandultrasonographyinpatientswithsecondaryhyperparathyroidism
AT guoyuanqing comparativeeffectivenessofmri4dctandultrasonographyinpatientswithsecondaryhyperparathyroidism
AT honghaiyu comparativeeffectivenessofmri4dctandultrasonographyinpatientswithsecondaryhyperparathyroidism
AT chimengshi comparativeeffectivenessofmri4dctandultrasonographyinpatientswithsecondaryhyperparathyroidism
AT liyongfang comparativeeffectivenessofmri4dctandultrasonographyinpatientswithsecondaryhyperparathyroidism
AT hepeng comparativeeffectivenessofmri4dctandultrasonographyinpatientswithsecondaryhyperparathyroidism
AT gaojiebing comparativeeffectivenessofmri4dctandultrasonographyinpatientswithsecondaryhyperparathyroidism
AT liaowei comparativeeffectivenessofmri4dctandultrasonographyinpatientswithsecondaryhyperparathyroidism